No photo of Matthew Krebs

Matthew Krebs, MB ChB FRCP PhD

Dr

If you made any changes in Pure these will be visible here soon.

Personal profile

Overview

Early phase clinical trials (e.g. first-in-human drugs or novel combinations of targeted/immuno-oncology therapies) with a focus in drug development for lung cancer

Precision medicine lead in Experimental Cancer Medicine Team, The Christie NHS Foundation Trust.

Translational circulating biomarker research

Personalised medicine with hypothesis-driven early phase clinical trials in biomarker-enriched populations 

Qualifications

Fellow of Royal College of Physicians (London), UK, 2019

PhD in Experimental Pharmacology and Circulating Biomarkers, University of Manchester 2011

Member of Royal College of Physicians (London), UK, 2005

Bachelor of Medicine and Bachelor of Surgery (MB ChB), University of Leicester, 2001

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics where Matthew Krebs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • ESMO 2018

    Matthew Krebs (Chair)

    Dec 2016Oct 2018

    Activity: Participating in or organising event(s)Participating in a conference, workshop, exhibition, performance, inquiry, course etcResearch